# Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

> **NCT01385280** · NA · COMPLETED · sponsor: **University of Arizona** · enrollment: 13 (actual)

## Conditions studied

- Estrogen Receptor-positive Breast Cancer
- Progesterone Receptor Positive Tumor
- Recurrent Breast Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **BIOLOGICAL:** therapeutic estradiol
- **DRUG:** exemestane
- **OTHER:** laboratory biomarker analysis
- **OTHER:** enzyme-linked immunosorbent assay

## Key facts

- **NCT ID:** NCT01385280
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385280, "Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01385280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*